<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04521842</url>
  </required_header>
  <id_info>
    <org_study_id>WarsawMU/Head</org_study_id>
    <nct_id>NCT04521842</nct_id>
  </id_info>
  <brief_title>Influence of Femoral Head Size During Total Hip Arthroplasty on Gait</brief_title>
  <official_title>Influence of Large Head vs Standard Size During Total Hip Arthroplasty on Gait Analysis - Prospective Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Warsaw</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Warsaw</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Total hip replacement (THR) is being considered as one of the most effective medical&#xD;
      procedures. Since its introduction, there was a worldwide debate over proper implant&#xD;
      selection in terms of size, bearing type and shape. The diameter of used femoral heads&#xD;
      components grew throughout the years - from 22 mm in the 1960s to 32 mm in the 2000s, which&#xD;
      is the most commonly used size nowadays. In recent years there was a visible use of large&#xD;
      femoral heads (&gt;=36mm) in several registers. In the USA there was a significant grow in use&#xD;
      of this heads rising from 1% in early 200s to even 58% in 2009. There is a strong evidence&#xD;
      data and many researchers concerning range of movement, risk of dislocation, functional&#xD;
      results, pain and prosthesis wear depending of femoral head size.&#xD;
&#xD;
      In terms of gait characteristics there are several deviations reported concerning both&#xD;
      patients with hip osteoarthritis (OA) and following THR. There is a lack of literature&#xD;
      concerning influence of used implants on gait parameters and whether this goal of the surgery&#xD;
      can be achieved.&#xD;
&#xD;
      The aim of this study was to assess potential differences of lower limb biomechanics during&#xD;
      gait in patients following total hip replacement surgery depending on femoral head diameter&#xD;
      and compare them to the normal gait of healthy volunteers. As a secondary outcome authors&#xD;
      wanted to inspect correlation between gait parameters and patient-reported outcome.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Total hip replacement (THR) is being considered as one of the most effective medical&#xD;
      procedures. Since its introduction, there was a worldwide debate over proper implant&#xD;
      selection in terms of size, bearing type and shape. The diameter of used femoral heads&#xD;
      components grew throughout the years - from 22 mm in the 1960s to 32 mm in the 2000s, which&#xD;
      is the most commonly used size nowadays. In recent years there was a visible use of large&#xD;
      femoral heads (&gt;=36mm) in several registers. In the USA there was a significant grow in use&#xD;
      of this heads rising from 1% in early 200s to even 58% in 2009. There is a strong evidence&#xD;
      data and many researchers concerning range of movement, risk of dislocation, functional&#xD;
      results, pain and prosthesis wear depending of femoral head size.&#xD;
&#xD;
      In terms of gait characteristics there are several deviations reported concerning both&#xD;
      patients with hip osteoarthritis (OA) and following THR. It is well-proven that those with&#xD;
      hip OA have reduced stride length and reduced cadence, reduced gait velocity, and reduced&#xD;
      joint excursion. Patients after THR walk with lower hip-abduction moments, sagittal-plane&#xD;
      range of motion. It is believed that it might be a consequence of pain-avoidance mechanism&#xD;
      developed as an adaptation for joint disease, which is still present after the surgery. What&#xD;
      is more, there are publications, which underline that lower limb biomechanics during gait do&#xD;
      not return to normal following THR.&#xD;
&#xD;
      However there is a lack of literature concerning influence of used implants on gait&#xD;
      parameters and whether this goal of the surgery can be achieved.&#xD;
&#xD;
      According to authors best knowledge this study is the first to ever describe potential&#xD;
      differences in gait parameters between THR performed with standard femoral heads (28-32mm)&#xD;
      and large ones (&gt;=36mm).&#xD;
&#xD;
      Aim of the study The aim of this study was to assess potential differences of lower limb&#xD;
      biomechanics during gait in patients following total hip replacement surgery depending on&#xD;
      femoral head diameter and compare them to the normal gait of healthy volunteers. As a&#xD;
      secondary outcome authors wanted to inspect correlation between gait parameters and&#xD;
      patient-reported outcome.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2016</start_date>
  <completion_date type="Actual">September 2020</completion_date>
  <primary_completion_date type="Actual">July 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients qualified to undergo total hip arthroplasty due to the end-stage osteoarthritis will be randomly allocated to receive either standard femoral head size implants nor large ones. Pre- and postoperatively they will undergo gait analysis. To avoid risk of bias assessor will be blinded in terms of used implants in every participants case.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time of swing phase</measure>
    <time_frame>at least 3,5 years after surgery</time_frame>
    <description>Change from baseline part of swing phase time during gait, measured in percentage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time of stance phase</measure>
    <time_frame>at least 3,5 years after surgery</time_frame>
    <description>Change from baseline part of stance phase time during gait, measured in percentage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time of double-stance phase</measure>
    <time_frame>at least 3,5 years after surgery</time_frame>
    <description>Change from baseline part of double-stance phase time during gait, measured in percentage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stride length</measure>
    <time_frame>at least 3,5 years after surgery</time_frame>
    <description>Change from baseline length of stride during gait, measured in meters</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cadence</measure>
    <time_frame>at least 3,5 years after surgery</time_frame>
    <description>Change from baseline number of strides per minute of walking</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean gait velocity</measure>
    <time_frame>at least 3,5 years after surgery</time_frame>
    <description>Change from baseline mean values of gait speed, measured in meters per second</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Range of maximal hip extension for both limbs during ending part of mid-stance phase</measure>
    <time_frame>at least 3,5 years after surgery</time_frame>
    <description>Change from baseline range of maximal hip extension for both limbs during ending part of mid-stance phase, measured in degrees</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Range of pelvic drop in frontal plane on the opposite site of the bearing limb</measure>
    <time_frame>at least 3,5 years after surgery</time_frame>
    <description>Change from baseline range of pelvic drop in frontal plane on the opposite site of the bearing limb, measured in degrees</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Osteoarthritis, Hip</condition>
  <condition>Hip Arthritis</condition>
  <condition>Gait, Frontal</condition>
  <arm_group>
    <arm_group_label>Standard size femoral head implant</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants qualified to undergo total hip replacement who will receive standard femoral head size implant</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Large size femoral head</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants qualified to undergo total hip replacement who will receive large femoral head size implant</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Total hip replacement</intervention_name>
    <description>Total hip replacement in treatment of end-stage osteoarthritis</description>
    <arm_group_label>Large size femoral head</arm_group_label>
    <arm_group_label>Standard size femoral head implant</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  BMI &lt;35&#xD;
&#xD;
          -  Ability to walk for 10 meters&#xD;
&#xD;
          -  60-80 years of age&#xD;
&#xD;
          -  Bilateral THR&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Revision surgeries before and after THR&#xD;
&#xD;
          -  Any other lower limbs surgeries&#xD;
&#xD;
          -  Secondary OA&#xD;
&#xD;
          -  Neurological disorders&#xD;
&#xD;
          -  Cardiac disorders&#xD;
&#xD;
          -  Severly impaired balance&#xD;
&#xD;
          -  Severe dizziness&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bartosz M. MaciÄ…g, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Warsaw</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Othopedics and Rehabilitation, Medical University of Warsaw</name>
      <address>
        <city>Warsaw</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>August 10, 2020</study_first_submitted>
  <study_first_submitted_qc>August 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 21, 2020</study_first_posted>
  <last_update_submitted>October 5, 2021</last_update_submitted>
  <last_update_submitted_qc>October 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>osteoarthritis</keyword>
  <keyword>hip</keyword>
  <keyword>gait</keyword>
  <keyword>walk</keyword>
  <keyword>biomechanics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Hip</mesh_term>
    <mesh_term>Gait Disorders, Neurologic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The datasets used and/or analyzed during the current study will be available from the corresponding author on reasonable request.</ipd_description>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>The datasets used and/or analyzed during the current study will be available from the corresponding author on reasonable request.</ipd_time_frame>
    <ipd_access_criteria>The datasets used and/or analyzed during the current study will be available from the corresponding author on reasonable request.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

